Affimed GmbH
We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ lives. Inspired by the immense potential of the innate immune system, we are dedicated to unlocking profound possibilities—bringing new hope to those whose lives have been forever changed by the impact of cancer. With broad expertise in innate immunity, tumor biology, and antibody engineering, we are well situated to advance our unique and insightful approach for activating the innate immune system to fight cancer. Our novel and proprietary technology will allow us to develop and commercialize groundbreaking treatments across multiple tumor types.. Genentech will be responsible for clinical development and commercialization worldwide.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About us
A one-of-a-kind approach for revolutionary outcomes
We are revolutionizing cancer treatment by activating the untapped power of the innate immune system to eradicate tumors. Our novel and proprietary technology binds NK cells and other innate immune cells directly to tumor cells, allowing for tumor destruction.
This approach is versatile and scalable.
Our approach is differentiated and IP-protected, and has the promise to help patients who have already undergone earlier lines of therapy that proved to be unsuccessful.
Partnerships poised to change the treatment landscape
We have entered select partnerships with esteemed pharmaceutical companies who share our passion for bringing change to the treatment of cancer.
We trust that we can help those who have been left behind due to a lack of efficacy or unpredictable toxicity with traditional therapies. Clinical results already light the way for patients suffering from multiple types of cancer. Initial reported data have demonstrated unprecedented ORR in patients who had undergone earlier lines of therapy that proved to be unsuccessful—including one patient who was about to enter hospice care.
Our Mission
We are a team of innate immunity experts who are unrelenting in our efforts to change the meaning of cancer
With our differentiated approach to arming the body’s innate immune system, we are focused on delivering new treatments beyond the limitations of existing therapies.
Our Mission and Vision
The goal we strive to achieve, every day
To stop cancer from ever derailing patients’ lives.
